Posted inBiotechnology
The Impact of Gender on Sleep Development
Sleep occupies a critical portion of life, evolving alongside brain development from infancy to adulthood. Recent findings underscore the importance…
Posted inBiotechnology
JPM25: Kyverna’s new CEO sets priorities for cell therapy biotech riding the autoimmune wave
About 100 days into the CEO role at Kyverna Therapeutics, Warner Biddle has determined the strategic priorities for the California…
Posted inBiotechnology
JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal…
Posted inBiotechnology
Gilead roars into JPM25, inking $1.7B inflammation deal with Leo Pharma
Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than before,…
Posted inBiotechnology
Obesity-focused Metsera files IPO just nine months after emerging
Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. The…
Posted inBiotechnology
Scientists Develop Bacteria-Repellent Surfaces That Promote Cell Growth
image: The team have shown that their nanostructured surfaces resist the growth of bacteria, but enable the culturing of cells.…
Posted inBiotechnology
Scientists Develop Bacteria-Resistant Substrates That Promote Cell Growth
Tokyo Metropolitan University has recently made a significant advancement in the realm of biomaterials through the development of anodic porous…
Posted inBiotechnology
Promising New Tablet Offers Hope for Controlling and Eradicating Intestinal Worms
A significant breakthrough in the treatment of soil-transmitted helminthiases has emerged from a clinical trial led by the Barcelona Institute…
Posted inBiotechnology
New Treatment for Widespread Parasitic Infections: Phase II-III Trial Demonstrates Safety and Enhanced Efficacy
Researchers are heralding a significant breakthrough in the fight against intestinal parasites that afflict approximately 1.5 billion people globally. The…
Posted inBiotechnology
UTHealth Houston Secures $2.9M Grant to Revamp Clinical Trials for Neurological Disorders in Underserved Communities
In a groundbreaking initiative aimed at addressing disparities in neurological outcomes, UTHealth Houston has secured a significant grant of $2.9…